Show simple item record

Prognostic and clinical significance of expressions of P53, ERBB2, c-Kit and BCL2 in childhood medulloblastoma

dc.contributor.authorÖZKAN, FERDA
dc.contributor.authorOz, Buge
dc.contributor.authorÖZKAN, Mustafa Alp
dc.contributor.authorCELKAN, Tülin Tıraje
dc.contributor.authorAPAK, Hilmi
dc.contributor.authorOcak, Suheyla
dc.date.accessioned2021-03-06T21:33:32Z
dc.date.available2021-03-06T21:33:32Z
dc.date.issued2019
dc.identifier.citationOcak S., ÖZKAN M. A. , ÖZKAN F., Oz B., CELKAN T. T. , APAK H., "Prognostic and clinical significance of expressions of P53, ERBB2, c-Kit and BCL2 in childhood medulloblastoma", CUKUROVA MEDICAL JOURNAL, cilt.44, ss.1-6, 2019
dc.identifier.othervv_1032021
dc.identifier.otherav_ff345d51-81fc-4b75-ba64-9bd39362e625
dc.identifier.urihttp://hdl.handle.net/20.500.12627/166854
dc.identifier.urihttps://doi.org/10.17826/cumj.442463
dc.description.abstractPurpose: The objective of this study is to evaluate prognostic implications of clinical, histopathological features and immuhistochemical expressions of p53, ERBB2, c-Kit and Bcl-2 in pediatric medulloblastoma.
dc.language.isoeng
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectTIP, GENEL & İÇECEK
dc.titlePrognostic and clinical significance of expressions of P53, ERBB2, c-Kit and BCL2 in childhood medulloblastoma
dc.typeMakale
dc.relation.journalCUKUROVA MEDICAL JOURNAL
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume44
dc.identifier.issue1
dc.identifier.startpage1
dc.identifier.endpage6
dc.contributor.firstauthorID260756


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record